Trial Details
COMPLETEDBasic Information
| Clinical ID | c2457 |
|---|---|
| Identifier | NCT03464136 |
| Trial Title | Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn Disease |
| Interventions | BIOLOGICAL: Placebo for Ustekinumab|BIOLOGICAL: Placebo for Adalimumab|BIOLOGICAL: Ustekinumab (6 mg/kg)|BIOLOGICAL: Ustekinumab (90 mg)|BIOLOGICAL: Adalimumab (40 mg) |
Participant Information
| Sponsor | Janssen Scientific Affairs, LLC |
|---|---|
| City | Mobile |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2018-03-29 |
|---|---|
| Primary Completion Date | 2020-12-15 |
| Completion Date | 2021-05-21 |